 Regain The Memory Of Your Youth With Vinpocetine! Vinpocetine is a member of the “smart drug” family, and is a semi-synthetic drug derived from Vincamine, a component extracted from the periwinkle plant. It is believed, when taken regularly, to improve cerebral blood flow, oxygen, energy, and improve memory and cognition. Described as a vasodilator, Vinpocetine protects against brain arteriosclerosis, which if left unchecked, may lead to a stroke. Moreover, it appears only to affect the areas of the brain that require treatment. This action has seen Vinpocetine being used to improve hearing (particularly tinnitus), eyesight difficulties, and to alleviate menopausal symptoms. What Does The Research Say? Vinpocetine has been the subject of many research studies in different countries over the years, and conclusions have been drawn highlighting improvements in blood circulation, oxygen uptake and glucose utilization in the brain. Research carried out by Kiss and Karpati (1996) demonstrated an improvement in cerebral circulation and oxygen utilization without precipitating changes in systemic circulation, certain cerebral protection mechanisms, cognition-enhancing and anticonvulsant activity. Szobor and Klein (1976) undertook research to determine the effectiveness of Vinpocetine in 100 patients with neurovascular diseases. Divided into two groups, forty six patients were given combined treatments in a daily dose of 10-30 mg. The remaining 54 patients were treated with oral Vinpocetine of 30-45 mg daily. Vinpocetine demonstrated significant improvements in the reversible vascular diseases of hypertensive encephalopathy, intermittent vascular cerebral insufficiency and cerebral arteriosclerosis. Balestreri et al. (1987) documented the effects of Vinpocetine in a double blind clinical trial involving 42 elderly patients with chronic cerebral dysfunction. In this study, the patients received 10mg of Vinpocetine three times daily for a month, then 5mg for two months. Improvements were noted in memory functions, as measured by the Clinical Global Impression scale, the Sandoz Clinical Assessment-Geriatric scale and the Mini-Mental Status Questionnaire. 09/10/2007 GI | 
